AlloVir (ALVR) Revenue & Revenue Breakdown
AlloVir Revenue Highlights
00
Main Segment (Y)
Grant
Main Geography (Y)
Grant
AlloVir Revenue by Period
AlloVir Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | -100.00% |
2019-12-31 | $165.00K | -85.46% |
2018-12-31 | $1.14M | - |
AlloVir Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $8.38M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | -100.00% |
2019-03-31 | $165.00K | - |
AlloVir Revenue Breakdown
AlloVir Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 20 |
---|---|
Grant | $900.00K |
Latest
Quarterly Revenue by Product
Product/Service | Dec 20 | Sep 20 | Jun 20 |
---|---|---|---|
Grant | $200.00K | $400.00K | $300.00K |
Latest
AlloVir Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 20 |
---|---|
Grant | $900.00K |
Latest
Quarterly Revenue by Country
Country | Dec 20 | Sep 20 | Jun 20 |
---|---|---|---|
Grant | $200.00K | $400.00K | $300.00K |
Latest
AlloVir Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MRUS | Merus | $43.95M | $11.77M |
AGIO | Agios Pharmaceuticals | $26.82M | $8.96M |
ADAG | Adagene | $18.11M | $833.34K |
ANAB | AnaptysBio | $17.16M | $30.02M |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
KRON | Kronos Bio | $6.29M | $2.37M |
CRNX | Crinetics Pharmaceuticals | $4.01M | - |
INBX | Inhibrx Biosciences | $1.80M | - |
FIXX | Q32 Bio | $1.16M | - |
BCEL | Atreca | $770.00K | $80.00K |
LYEL | Lyell Immunopharma | $130.00K | $34.00K |
ANEB | Anebulo Pharmaceuticals | - | - |
CGEM | Cullinan Oncology | - | - |
ALVR | AlloVir | - | - |
BDTX | Black Diamond Therapeutics | - | - |
ANTX | AN2 Therapeutics | - | - |
AVTE | Aerovate Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
MLYS | Mineralys Therapeutics | - | - |
FDMT | 4D Molecular Therapeutics | - | - |